Study links GLP-1 use to some pregnancy risks — but the study has key caveats

Postpartum Prescription of GLP-1 Drugs Has Increased Sharply, Study Finds

Danish researchers were examining the use of medications during and after pregnancy when they noticed a clear trend: The number of women using weight-loss drugs like Ozempic and Wegovy soon after childbirth had risen sharply. In 2018, few women were using the drugs during the first six months after having a baby, with fewer than five prescriptions for every 10,000 new mothers. By mid-2022, that figure had increased to 34 prescriptions for every …

The complicated relationship between GLP-1s and pregnancy

People who stopped taking weight-loss drugs before or during pregnancy were associated with greater gestational weight gain and had a higher risk of preterm delivery and gestational diabetes compared with those who had not been prescribed the drugs before, according…

Study links GLP-1 use to some pregnancy risks — but the study has key caveats

A new study hints that pregnant people who have previously taken drugs like Ozempic may face a higher risk of certain poor pregnancy outcomes. But more studies are needed to understand the finding.